Impact analysis of expanded access to ketamine for treatment-resistant depression.
Journal of comparative effectiveness research June 1, 2025 Thanh Lu, Sophia D'Angelo, Zohra Tayebali et al.
Aim: This study aimed to estimate the economic impacts of expanded access to ketamine relative to electroconvulsive therapy (ECT) by offering intravenous ketamine to US patients with nonpsychotic treatment-resistant depression (TRD) and moderate-to-severe depression. Materials & methods: A population-level Markov simulation model with key parameters from a randomized trial was used to simulate...